Posted on October 12, 202010/12/20
Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines
Posted on August 10, 20208/10/20
Japan Outlines Measures to Ensure Stable Drug Supply
Posted on June 15, 20206/15/20
Japan Pharma Association Introduces Bold Policy Measures to Reform Sector
Posted on May 13, 20205/13/20
Zolgensma Proposed to Cost 167 Million Yen in Japan
Posted on April 13, 20204/13/20
Japan’s PMDA Evaluates Side Effects of Insulins, Cancer Drugs
Posted on March 31, 20203/31/20